ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693118 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693118; 2) Community: the network communities that were significantly associated with the response to NSC 693118; 3) Molecule: the relationships between components within communities and NSC 693118; 4) MDR: the compounds that were significantly associated with the NSC 693118.

NSC Compound Enrichment Correlation
NSC 610459 Camptothecin Derivative 0.0181211508101519 0.56711331
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0181211508101519 0.41459773
NSC 631075 Null 0.0181211508101519 -0.10209815
NSC 639186 Raltitrexed 0.0181211508101519 0.44832606
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0181211508101519 0.67556904
NSC 662123 Null 0.0181211508101519 0.19026876
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.0181211508101519 0.62552905
NSC 679287 Null 0.0181211508101519 0.42705263
NSC 680300 Null 0.0181211508101519 0.33310986
NSC 681639 Camptothecin Derivative 0.0181211508101519 0.64375639
Total:78  Current:33    [First] [Prev] [Next] [Last]